Fagron NV FAGRON ORD SHS/ BE0003874915 /
2024-05-24 10:58:28 AM | Chg. - | Volume | Bid5:40:04 PM | Ask5:40:04 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
18.21EUR | - | 1,436 Turnover: 26,433.30 |
-Bid Size: - | -Ask Size: - | 1.38 bill.EUR | 1.59% | 19.40 |
GlobeNewswire
01-30
MasterControl Launches Advanced Quality Event Management Software to Streamline Quality Processes
GlobeNewswire
2021-10-07
MasterControl Honors Customers’ Success in Quality and Innovation at the Annual Masters of Excellen...
GlobeNewswire
2021-03-23
Fagron Expands Use of MasterControl’s Quality Excellence to 8 European Sites
GlobeNewswire
2019-06-26
Fagron NV: Fagron reaches settlement in principle with US Department of Justice
GlobeNewswire
2019-06-03
U.S. Compounding Pharmacies Market is Expected to Reach Around US$ 14 Bn by the End of 2028 – Future...
GlobeNewswire
2019-02-07
Fagron realized turnover growth of 14.5%; REBITDA increased to € 99.1 million
GlobeNewswire
2018-10-11
Fagron continues strong turnover growth of first semester in the third quarter of 2018
GlobeNewswire
2018-09-18
Compounding Pharmacies Market to Reach US$ 13,366.5 Mn by 2025 – Persistence Market Research
GlobeNewswire
2018-07-12
Sequana Medical Announces the Appointment of Kirsten Van Bockstaele as Chief Financial Officer
GlobeNewswire
2018-04-13
Fagron NV: Convocation annual general meeting and extraordinary general meeting
GlobeNewswire
2018-04-03
Fagron strengthens strategic position in USA through highly complementary acquisition of Humco
GlobeNewswire
2018-02-07
Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to € 47.0 million